Perry Calias
7Patents
5h-index
5Co-inventors
52Inventor score
Filing activity: Aug 26, 2004 → Mar 10, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7759472B2 | Combination therapy for the treatment of ocular neovascular disorders | Human Necessities | 23 | Expired |
| US8206707B2 | Combination therapy for the treatment of ocular neovascular disorders | Human Necessities | 22 | Active |
| US8187597B2 | Combination therapy for the treatment of ocular neovascular disorders | Human Necessities | 15 | Active |
| US10376463B2 | Ocular iontophoretic delivery of dexamethasone and formulations thereof | Human Necessities | 5 | Active |
| US8685397B2 | Combination therapy for the treatment of ocular neovascular disorders | Human Necessities | 5 | Active |
| US9149525B2 | Delivery of corticosteroids through iontophoresis | Human Necessities | 1 | Active |
| US9820935B2 | Delivery of corticosteroids through iontophoresis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.